Biopharma is set to lose two of the industry’s rare women CEOs—GSK’s Emma Walmsley and Merck KGaA's Belén Garijo—leaving a dearth of women-helmed large life sciences companies. The Life Sciences are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback